Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement

Authors

  • Silvana Capalbo Hematology Section, Department of Internal Medicine and Public Medicine, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124, Bari, Italy
  • Antonia Chiefa Hematology Section, Department of Internal Medicine and Public Medicine, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124, Bari, Italy
  • Mario Delia Hematology Section, Department of Internal Medicine and Public Medicine, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124, Bari, Italy
  • Daniela Diomede Hematology Section, Department of Internal Medicine and Public Medicine, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124, Bari, Italy
  • Vincenzo Liso Hematology Section, Department of Internal Medicine and Public Medicine, University of Bari, Policlinico, Piazza Giulio Cesare 11, 70124, Bari, Italy

DOI:

https://doi.org/10.1080/02841860600897975

Abstract

No Abstracts Available

Downloads

Download data is not yet available.

Downloads

Published

2007-01-01

How to Cite

Capalbo, S., Chiefa, A., Delia, M., Diomede, D., & Liso, V. (2007). Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement. Acta Oncologica, 46(2), 262–264. https://doi.org/10.1080/02841860600897975